Product Information
POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.1336 per EA under NDC 00591268201. Its NADAC has been published 425 times since Jul 4, 2018.
FDA first approved this application on Mar 5, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 meq/1
Manufacturer
Actavis Pharma, Inc.NDC
00591268201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209758FDA Approved
3/5/2018
TE Code
AB
On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 425 times since Jul 4, 2018, and over the history we have for it it has declined 80.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1336 per EA |
|---|---|
| All-time high | $0.8278 (Sep 12, 2018) |
| All-time low | $0.1064 (May 22, 2024) |
| 52-week high | $0.1419 |
| 52-week low | $0.1217 |
| Median price | $0.3686 |
| Average price | $0.3896 |
| Largest weekly change | +79.1% (Jan 18, 2023) |
| Weeks tracked | 425 |
| Tracking since | Jul 4, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Actavis Pharma, Inc., is $0.1336 per EA (NDC 00591268201), effective Aug 19, 2026.
How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 80.7%. It has been tracked across 425 weekly CMS publications since Jul 4, 2018.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?
Since Jul 4, 2018, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.8278 (Sep 12, 2018), with a median of $0.3686 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 5 MEQ TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?
POTASSIUM CITRATE ER 5 MEQ TAB (NDC 00591268201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.